These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

703 related items for PubMed ID: 187429

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V, Lahaye T, Horvath C, Zanovello P, Collavo D, Engers HD.
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [Abstract] [Full Text] [Related]

  • 4. Characterization of effector lymphocytes associated with immunity to murine sarcoma virus (MSV) induced tumors. I. Physical properties of cytolytic T lymphocytes generated in vitro and of their immediate progenitors.
    Plata R, MacDonald HR, Engers HD.
    J Immunol; 1976 Jul; 117(1):52-8. PubMed ID: 180182
    [Abstract] [Full Text] [Related]

  • 5. Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro.
    Ryser JE, Cerottini JC, Brunner KT.
    Eur J Immunol; 1979 Mar; 9(3):179-84. PubMed ID: 221224
    [Abstract] [Full Text] [Related]

  • 6. Suppressor T cells regulate the cytolytic T lymphocyte response to syngeneic tumors induced by murine sarcoma virus (MSV) in the mouse.
    Plata F, MacDonald HR, Shain B.
    J Immunol; 1979 Aug; 123(2):852-60. PubMed ID: 156765
    [Abstract] [Full Text] [Related]

  • 7. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E, Bonavida B.
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [Abstract] [Full Text] [Related]

  • 8. [Functional activity of cytolytic T lymphocytes in the rejection of tumor target cells].
    Brunner KT, Cerottini JC.
    Ann Immunol (Paris); 1977 Nov; 128(1-2):473-83. PubMed ID: 139840
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors.
    Biasi G, Saggin L, Dazzi F, De Rossi A, Collavo D.
    J Immunol; 1983 Mar; 130(3):1447-50. PubMed ID: 6185589
    [Abstract] [Full Text] [Related]

  • 12. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M, Orosz CG, Bach FH.
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [Abstract] [Full Text] [Related]

  • 13. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR.
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [Abstract] [Full Text] [Related]

  • 14. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D, Parenti A, Biasi G, Chieco-Bianchi L, Colombatti A.
    J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
    [Abstract] [Full Text] [Related]

  • 15. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH, Daynes RA, Hodes RJ.
    J Immunol; 1986 Feb 15; 136(4):1521-7. PubMed ID: 2418117
    [Abstract] [Full Text] [Related]

  • 16. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection.
    Jiang D, Flyer DC.
    J Immunol; 1992 Feb 01; 148(3):974-80. PubMed ID: 1730885
    [Abstract] [Full Text] [Related]

  • 17. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. II. Analysis of the clonal progeny of CTL precursors stimulated in vitro with syngeneic tumor cells.
    Brunner KT, MacDonald HR, Cerottini JC.
    J Immunol; 1980 Apr 01; 124(4):1627-34. PubMed ID: 6154076
    [No Abstract] [Full Text] [Related]

  • 18. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
    Toffaletti DL, Darrow TL, Scott DW.
    J Immunol; 1983 Jun 01; 130(6):2982-6. PubMed ID: 6189910
    [Abstract] [Full Text] [Related]

  • 19. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K, Nakashima I, Nagase F, Isobe K, Kawashima K, Hasegawa Y, Yoshida T, Iwamoto T, Hasegawa T, Muro Y.
    J Immunol; 1988 Feb 01; 140(3):723-9. PubMed ID: 2448374
    [Abstract] [Full Text] [Related]

  • 20. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC, Burakoff SJ, Faller DV.
    J Immunol; 1985 Oct 01; 135(4):2287-92. PubMed ID: 2411792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.